Registration of securities issued in business combination transactions

Statements of Operations and Comprehensive Loss

v3.20.1
Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating costs and expenses:    
Research and development (a) [1] $ 6,126,972 $ 12,259,940
Patent costs 146,281 204,396
General and administrative 4,570,932 5,425,033
Total operating costs and expenses 10,844,185 17,889,369
Operating loss (10,844,185) (17,889,369)
Other income:    
Interest income 123,052 126,835
Settlement of accounts payable (a) [1] 588,114 893,823
Total other income 711,166 1,020,658
Net loss (10,133,019) (16,868,711)
Other comprehensive gain (loss):    
Unrealized gain (loss) on debt securities 923 (923)
Comprehensive loss (10,132,096) (16,869,634)
Net Loss (10,133,019) (16,868,711)
Deemed dividend of preferred stock (2,537,844)
Net loss applicable to common stockholders $ (10,133,019) $ (19,406,555)
Net loss per common share - basic and diluted $ (1.06) $ (3.66)
Weighted average common shares outstanding - basic and diluted 9,570,061 5,304,667
[1] For comparative presentation purposes, settlement of accounts payable of $893,823 for the year ended December 31, 2018 was reclassified out of research and development and into settlement of accounts payable under other income.